Evidence map›Paper›PMID 24590276›Full record

ReviewThe Journal of clinical investigation2014

New developments in clinical aspects of lymphatic disease.

Peter S Mortimer, Stanley G Rockson

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 140 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 3 pooled it
10.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06554912 nawithdrawnnot on this mapstarted 2024, after this paper: background citation

Evaluation of Safety and Feasibility of Lymphatic Decompression in Chronic Heart Failure

TypeinterventionalSponsorUniversity Hospital, GrenobleRan2024 to 2024Enrolled0ConditionsCardiovascular Diseases, Chronic Heart FailureArmsLymphatic Decompression
NCT07489248 recruitingnot on this mapstarted 2026, after this paper: background citation

Ultrasonographic evaluation of lower extremity skin and subcutaneous tissue with quantitative echogenicity and elastography in lymphedema, lipedema, and healthy control groups: a controlled clinical study

TypeobservationalSponsorKayseri City HospitalRan2026 to 2026Enrolled75ConditionsLymphedema, LipedemaArmsMultimodal Ultrasound Assessment
3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 3 syntheses or guidelines pooled it, 339 citations in OpenAlex.

  1. Pooled it
  2. Lipedema: Progress, Challenges, and the Road Ahead.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  3. Interventions for the prevention of recurrent erysipelas and cellulitis.The Cochrane database of systematic reviews · 2017
    Pooled it
  4. Trial
  5. Trial
  6. Social determinants drive lymphedema severity and treatment adherence: evidence from a three-year retrospective cohort study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Impact of cancer-related and primary lymphedema and compression bandaging on limb range of motion: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Journal of rural medicine : JRM · 2025
    Article
  19. Article
  20. Sleep quality and lymphedema in breast cancer survivors: a mixed method analysis.Journal of cancer survivorship : research and practice · 2025
    Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Peter S Mortimer
Stanley G Rockson
Stanford University · USUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lymphatic system is fundamentally important to cardiovascular disease, infection and immunity, cancer, and probably obesity--the four major challenges in healthcare in the 21st century. This Review will consider the manner in which new knowledge of lymphatic genes and molecular mechanisms has demonstrated that lymphatic dysfunction should no longer be considered a passive bystander in disease but rather an active player in many pathological processes and, therefore, a genuine target for future therapeutic developments. The specific roles of the lymphatic system in edema, genetic aspects of primary lymphedema, infection (cellulitis/erysipelas), Crohn's disease, obesity, cancer, and cancer-related lymphedema are highlighted.

Indexed as

AnimalsCellulitisCrohn DiseaseGenetic Predisposition to DiseaseHumansLymphadenitisLymphatic MetastasisLymphatic VesselsLymphedemaNeoplasmsObesity

Identifiers

PMID24590276
PMCPMC3938261
OpenAlexW2136930833

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.